Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Second-Guessing FDA: CMS' Expanding Regulatory Role

Oct 01 2010

• By Michael McCaughan

Related Content

Defining Line Extensions: Medicaid Rebate Change Gives CMS Power to take a Bite Out of Lifecycle Management

Apr 01 2010

Synagis' Special Status Under Health Care Reform

Oct 01 2010

The New Part D: "Dollars for Donuts" Becomes Discounts For Data

Jul 01 2010

Living in a Bipolar World: Implications of the EPO Safety Debate (Part 1)

Jul 01 2007

CMS' Change of Heart: Niaspan will be Covered Under Medicare Part D

May 01 2006

A Cold Shower For Viagra: How Congress Can Chill A Market

Dec 01 2005

Unapproved Drugs Become Unpaid Drugs, Effective January 1

Dec 01 2009

Related Companies

Dendreon Corporation

Additional Topics

Regulation Reimbursement Government Payers BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window